Compound ID | 1868
Class: Beta-lactam (carbapenem)
Spectrum of activity: | Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Carbapenems bind to all PBPs, with PBP2 and PBP4 as the highest-affinity targets |
Description: | Semisynthetic, derived from thienamycin, similar to ertapenem; clinical development only for China |
Institute where first reported: | Sihuan Pharmaceutical |
Year first mentioned: | 2015 |
Highest developmental phase: | Phase 3 (NCT04505683) |
Development status: | Active (as of 2022) |
Chemical structure(s): | |
Canonical SMILES: | C[C@@H]1[C@@H]2[C@@H]([C@@H](C)O)C(=O)N2C(=C1S[C@H]3C[C@@H](C(=O)NCC4=CC=C(C=C4)S(=O)(=O)N)NC3)C(=O)O |
Isomeric SMILES: | C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NCC4=CC=C(C=C4)S(=O)(=O)N)C(=O)O)[C@@H](C)O |
InChI: | InChI=1S/C22H28N4O7S2/c1-10-17-16(11(2)27)21(29)26(17)18(22(30)31)19(10)34-13-7-15(24-9-13)20(28)25-8-12-3-5-14(6-4-12)35(23,32)33/h3-6,10-11,13,15-17,24,27H,7-9H2,1-2H3,(H,25,28)(H,30,31)(H2,23,32,33)/t10-,11-,13+,15+,16-,17-/m1/s1 |
InChI Key: | JNSMRGMLNPEWLR-PDCLSYJBSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/58326208 |
External links: | |
Guide to Pharmacology: | benapenem |
Main Source: | https://journals.asm.org/doi/10.1128/AAC.02188-18 |